<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="discussion" dtd-version="3.0" xml:lang="EN">
<front>
<journal-meta><journal-id journal-id-type="nlm-ta">PLoS Med</journal-id><journal-id journal-id-type="publisher-id">PLoS</journal-id><journal-id journal-id-type="pmc">plosmed</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Medicine</journal-title></journal-title-group><issn pub-type="epub">1549-1676</issn><publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="publisher-id">10-PLME-RIT-4944R2</article-id><article-id pub-id-type="doi">10.1371/journal.pmed.1000353</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research in Translation</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Evidence-Based Healthcare</subject><subject>Neurological Disorders/Cerebrovascular Disease</subject><subject>Neurological Disorders/Neurointensive Care</subject><subject>Physiology</subject><subject>Public Health and Epidemiology/Global Health</subject><subject>Surgery/Neurosurgery</subject></subj-group></article-categories><title-group><article-title>The Persisting Burden of Intracerebral Haemorrhage: Can Effective Treatments Be Found?</article-title></title-group><contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Josephson</surname><given-names>Colin B.</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Frantzias</surname><given-names>Joseph</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Samarasekera</surname><given-names>Neshika</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Al-Shahi Salman</surname><given-names>Rustam</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group><aff id="aff1">          <addr-line>Division of Clinical Neurosciences, Centre for Clinical Brain Sciences, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom</addr-line>       </aff><author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">Rustam.Al-Shahi@ed.ac.uk</email></corresp>
<fn fn-type="con"><p><ext-link ext-link-type="uri" xlink:href="http://www.icmje.org/" xlink:type="simple">ICMJE</ext-link> criteria for authorship read and met: CBJ JF NS RASS. Agree with the manuscript's results and conclusions: CBJ JF NS RASS. Designed the experiments/the study: RASS. Analyzed the data: CBJ RASS. Collected data/did experiments for the study: CBJ. Wrote the first draft of the paper: CBJ. Contributed to the writing of the paper: CBJ JF NS RASS.</p></fn>
<fn><p>Research in Translation discusses health interventions in the context of translation from basic to clinical research, or from clinical evidence to practice.</p></fn>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn></author-notes><pub-date pub-type="collection"><month>10</month><year>2010</year></pub-date><pub-date pub-type="epub"><day>19</day><month>10</month><year>2010</year></pub-date><volume>7</volume><issue>10</issue><elocation-id>e1000353</elocation-id><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2010</copyright-year><copyright-holder>Josephson et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract abstract-type="toc">
<p>Colin Josephson, Rustam Al-Shahi Salman, and colleagues discuss the effectiveness of treatments for intracerebral haemorrhage.</p>
</abstract><funding-group><funding-statement>RA-SS is funded by a UK Medical Research Council clinician scientist fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="6"/></counts></article-meta>
</front>
<body><boxed-text id="pmed-1000353-box001" position="float"><sec id="s1a">
<title>Summary</title>
<p>Intracerebral haemorrhage (ICH) accounts for ∼10% and ∼20% of strokes in high and low-middle income countries, respectively, but ICH incidence and case fatality do not appear to be declining. Evidence supports organised stroke unit care and secondary prevention with blood pressure lowering after ICH. Ongoing randomised controlled trials of treatments that are either intended to limit early ICH growth, reduce perihaematomal oedema, or modify other key pathophysiological mechanisms underlying deterioration after acute ICH, offer hope for future improvements in outcome.</p>
</sec></boxed-text><sec id="s2">
<title>Introduction</title>
<p>Spontaneous intracerebral haemorrhage (ICH) that is apparently unrelated to trauma or an underlying vascular, neoplastic, or coagulopathic cause has incurred the same global burden over the past quarter of a century <xref ref-type="bibr" rid="pmed.1000353-Lovelock1">[1]</xref>,<xref ref-type="bibr" rid="pmed.1000353-vanAsch1">[2]</xref>. During the last decade, spontaneous ICH accounted for ∼10% of strokes in high income countries and ∼20% of strokes in low and middle income countries, where the one month case fatalities were 25%–35% and 30%–48%, respectively <xref ref-type="bibr" rid="pmed.1000353-Feigin1">[3]</xref>.</p>
<p>The incidence of ICH is higher in Asians <xref ref-type="bibr" rid="pmed.1000353-vanAsch1">[2]</xref>, and the major risk factors for spontaneous ICH without an identified cause (so-called primary ICH) are male gender, systemic arterial hypertension, excessive alcohol consumption, increasing age, smoking, and diabetes mellitus <xref ref-type="bibr" rid="pmed.1000353-Ariesen1">[4]</xref>. However, over the past quarter of a century, the incidence of primary ICH associated with pre-stroke hypertension seems to have declined, whereas there seems to have been an increase associated with antithrombotic use and presumed cerebral amyloid angiopathy in those aged ≥75 years <xref ref-type="bibr" rid="pmed.1000353-Lovelock1">[1]</xref>. Whilst primary prevention with antihypertensive medication is probably the most effective strategy to reduce the burden of ICH, could the management of ICH influence outcome?</p>
<p>The outcome after primary ICH seems to be worse than after a bleed secondary to an arteriovenous malformation <xref ref-type="bibr" rid="pmed.1000353-vanBeijnum1">[5]</xref>, which justifies thorough investigation for all patients (<xref ref-type="table" rid="pmed-1000353-t001">Table 1</xref>). However, there is a shortage of evidence and lack of consensus about who, when, and how to further investigate for a cause underlying ICH <xref ref-type="bibr" rid="pmed.1000353-Cordonnier1">[6]</xref>. There appears to be a modest association between ICH deep in the brain and hypertension, and between ICH in the lobes of the brain and cerebral amyloid angiopathy <xref ref-type="bibr" rid="pmed.1000353-Ritter1">[7]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Jackson1">[8]</xref>, but these associations by no means rule out the need for further investigation of patients who are likely to survive and benefit from the identification of a treatable underlying cause (<xref ref-type="table" rid="pmed-1000353-t001">Table 1</xref>) <xref ref-type="bibr" rid="pmed.1000353-Broderick1">[9]</xref>.</p>
<table-wrap id="pmed-1000353-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.1000353.t001</object-id><label>Table 1</label><caption>
<title>Investigations into Common Causes of Secondary Intracerebral Haemorrhage (ICH).</title>
</caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pmed-1000353-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.1000353.t001" xlink:type="simple"/><table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" colspan="1" rowspan="1">Investigation</td>
<td align="left" colspan="1" rowspan="1">Common Causes Identified by the Investigation</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Further history from patient and others</td>
<td align="left" colspan="1" rowspan="1">Undisclosed trauma, drug use</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Routine laboratory tests<xref ref-type="table-fn" rid="nt101">a</xref></td>
<td align="left" colspan="1" rowspan="1">Vasculitis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Liver cirrhosis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Neoplasm (secondary)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Infective endocarditis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Coagulation studies</td>
<td align="left" colspan="1" rowspan="1">Warfarin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Von Willebrand disease</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Vitamin K deficiency</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Factor VIII, IX, XIII deficiency</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Blood cultures</td>
<td align="left" colspan="1" rowspan="1">Infective endocarditis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Toxicology</td>
<td align="left" colspan="1" rowspan="1">Cocaine</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Amphetamines</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Human chorionic gonadotrophin (β-hCG)</td>
<td align="left" colspan="1" rowspan="1">Pregnancy</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cerebrospinal fluid analysis<xref ref-type="table-fn" rid="nt102">b</xref></td>
<td align="left" colspan="1" rowspan="1">Vasculitis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CT, CT angiography, CT venography</td>
<td align="left" colspan="1" rowspan="1">Neoplasm (primary or secondary)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Intracranial arterial aneurysm</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Intracranial arteriovenous malformation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Intracranial venous thrombosis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MRI, MR angiography, MR venography</td>
<td align="left" colspan="1" rowspan="1">Cavernous malformation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Intracranial arterial aneurysm</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Intracranial arteriovenous malformation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Haemorrhagic transformation of a cerebral infarction</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Neoplasm (primary or secondary)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cerebral catheter angiography</td>
<td align="left" colspan="1" rowspan="1">Intracranial arterial aneurysm</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Intracranial arteriovenous malformation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Dural arteriovenous fistula</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"/>
<td align="left" colspan="1" rowspan="1">Vasculitis</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Neuroradiologist review of brain imaging</td>
<td align="left" colspan="1" rowspan="1">All causes whose identification depends on brain imaging</td>
</tr>
</tbody>
</table></alternatives><table-wrap-foot><fn id="nt101"><label>a</label><p>Full blood count, electrolytes, creatinine, urea, liver function tests, inflammatory markers (ESR/CRP), electrocardiogram, chest radiograph.</p></fn><fn id="nt102"><label>b</label><p>Consider the risk of transtentorial herniation before undertaking.</p></fn><fn id="nt103"><label/><p>CT, computed tomography; MRI, magnetic resonance imaging.</p></fn></table-wrap-foot></table-wrap>
<p>Apart from identifying and treating underlying causes of ICH, this review focuses on other strategies to improve outcome, bearing in mind the pathophysiological mechanisms underlying clinical deterioration after ICH. We go on to address the treatments for primary ICH that are supported by randomised controlled trials (RCTs) and those that are not, and discuss which interventions appear to be the most promising in ongoing and future RCTs.</p>
</sec><sec id="s3">
<title>Pathophysiology of Acute ICH</title>
<p>In humans, known pathophysiological mechanisms underlying further clinical deterioration soon after ICH include hydrocephalus, intraventricular extension of ICH, and recurrent ICH <xref ref-type="bibr" rid="pmed.1000353-Qureshi1">[10]</xref>; pathological and radiological studies have illuminated additional mechanisms (<xref ref-type="fig" rid="pmed-1000353-g001">Figure 1</xref>). Human studies performing brain computed tomography within two time windows after ICH onset have documented haematoma expansion (<xref ref-type="fig" rid="pmed-1000353-g002">Figure 2</xref>)—either due to growth of the original haemorrhage or re-bleeding <xref ref-type="bibr" rid="pmed.1000353-Brott1">[11]</xref>–<xref ref-type="bibr" rid="pmed.1000353-Flibotte1">[21]</xref>—that is associated with poor outcome <xref ref-type="bibr" rid="pmed.1000353-Davis1">[12]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Leira1">[16]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Kazui1">[18]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Hemphill1">[22]</xref>. Imaging studies have demonstrated peri-haematomal hypoperfusion within the first week of ICH onset <xref ref-type="bibr" rid="pmed.1000353-Rosand1">[23]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Pascual1">[24]</xref>, but not an “ischaemic penumbra” <xref ref-type="bibr" rid="pmed.1000353-Zazulia1">[25]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Herweh1">[26]</xref>. However, there is evidence of a compensatory reduction in the metabolic rate, or a “metabolic penumbra”, around ICH <xref ref-type="bibr" rid="pmed.1000353-Zazulia1">[25]</xref>,, as well as peri-haematomal hyperglycolysis (possibly due to inflammation, excitotoxicity, spreading depression, or seizures) <xref ref-type="bibr" rid="pmed.1000353-Zazulia2">[27]</xref>. Perihaematomal oedema appears to be vasogenic (plasma-derived) <xref ref-type="bibr" rid="pmed.1000353-Butcher1">[28]</xref>, its volume may increase within 24 hours of ICH onset and peak within 14 days <xref ref-type="bibr" rid="pmed.1000353-Zazulia3">[29]</xref>–<xref ref-type="bibr" rid="pmed.1000353-Inaji1">[31]</xref>, and it may be caused or exacerbated by thrombin and activated platelets <xref ref-type="bibr" rid="pmed.1000353-Gebel2">[32]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Sansing2">[33]</xref>.</p>
<fig id="pmed-1000353-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.1000353.g001</object-id><label>Figure 1</label><caption>
<title>Selected pathophysiological mechanisms that have been identified in humans after acute, spontaneous intracerebral haemorrhage.</title>
<p>Shapes are approximate illustrations of when pathophysiological mechanisms are at their peak and their known durations. Uncertainties about the duration and intensity of mechanisms are indicated by dashed lines.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.1000353.g001" xlink:type="simple"/></fig><fig id="pmed-1000353-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pmed.1000353.g002</object-id><label>Figure 2</label><caption>
<title>Summary of selected radiological studies of spontaneous intracerebral haemorrhage growth.</title>
<p>Studies are organised in ascending order of the duration of the time window of the first computed tomogram. Manual calculations of haematoma volume used the ABC/2 method. We excluded data on patients taking anticoagulant drugs in these studies, and excluded studies from which data could not be extracted <xref ref-type="bibr" rid="pmed.1000353-Herold1">[77]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Kelley1">[78]</xref>, studies that incorporated patients already included in the summary above <xref ref-type="bibr" rid="pmed.1000353-Silva1">[79]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Jauch1">[80]</xref>, or studies in which interventions may have influenced haematoma growth <xref ref-type="bibr" rid="pmed.1000353-Anderson1">[58]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Qureshi2">[81]</xref>.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.1000353.g002" xlink:type="simple"/></fig>
<p>Animal models support the contributions to peri-haematomal oedema made by clot retraction, hydrostatic pressure, enhanced thrombin production, increased blood–brain barrier permeability, and products of erythrocyte lysis (such as haeme oxygenase-mediated liberation of iron from haeme rings) <xref ref-type="bibr" rid="pmed.1000353-Gebel2">[32]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Wagner1">[34]</xref>–<xref ref-type="bibr" rid="pmed.1000353-Levine1">[37]</xref>. ICH in animal models seems to trigger humoral and cellular inflammatory responses: the consequent migration and recruitment of neutrophils and activation of native microglia results in oxidative stress and neuronal necrosis <xref ref-type="bibr" rid="pmed.1000353-Weiss1">[38]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Power1">[39]</xref>, cytokines such as tumour necrosis factor α and interleukin 1-β lead to apoptosis <xref ref-type="bibr" rid="pmed.1000353-Mayne1">[40]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Holmin1">[41]</xref>, complement activation causes erythrocyte lysis <xref ref-type="bibr" rid="pmed.1000353-Xi1">[42]</xref>, and matrix metalloproteinases may result in oedema, necrosis, and blood–brain barrier disruption <xref ref-type="bibr" rid="pmed.1000353-Wang1">[43]</xref>.</p>
<p>A better understanding of the pathophysiology of ICH could emerge if the decline in human autopsy rates reverses <xref ref-type="bibr" rid="pmed.1000353-Ayoub1">[44]</xref>, and if animal models of ICH better represent human ICH <xref ref-type="bibr" rid="pmed.1000353-James1">[45]</xref>. Rodent models of ICH involve either stereotactic intraparenchymal infusion of autologous whole blood (which may cause simultaneous intraventricular or subarachnoid haemorrhage <xref ref-type="bibr" rid="pmed.1000353-Andaluz1">[46]</xref>), or injection of proteolytic bacterial collagenase (which incites a vigorous immune response in excess of that seen in humans <xref ref-type="bibr" rid="pmed.1000353-Andaluz1">[46]</xref>), after which very few animals die, which is quite unlike spontaneous ICH in humans <xref ref-type="bibr" rid="pmed.1000353-vanAsch1">[2]</xref>.</p>
</sec><sec id="s4">
<title>Treatments Shown to Be Beneficial in Humans, Either in a Meta-Analysis of RCTs or in a Single Large RCT</title>
<p>A Cochrane meta-analysis of 31 RCTs involving 6,936 participants showed that organised inpatient care in stroke units benefits patients with stroke (whether ischaemic or due to ICH) by reducing the odds of death or dependency by 18% <xref ref-type="bibr" rid="pmed.1000353-Stroke1">[47]</xref>. Large observational studies corroborate these findings in patients with ICH <xref ref-type="bibr" rid="pmed.1000353-Candelise1">[48]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Terent1">[49]</xref>. Which aspects of organized stroke care, either individually or together, improve outcome in patients with ICH remain to be determined. One small, non-randomised, observational analysis, which was adjusted for some of the known influences on ICH prognosis, found survival after ICH to be better when managed in neuro-intensive care units compared to general intensive care units <xref ref-type="bibr" rid="pmed.1000353-Diringer1">[50]</xref>: RCTs of some of the interventions used in the “black box” of neuro-intensive care (such as acute blood pressure lowering) are underway (see below). Furthermore, the benefits of standard care can be inferred from the effects on clinical outcome of do-not-resuscitate orders in a case-mix adjusted multi-hospital observational study <xref ref-type="bibr" rid="pmed.1000353-Hemphill2">[51]</xref>, and withdrawal of care in a multivariable analysis at a single hospital <xref ref-type="bibr" rid="pmed.1000353-Becker1">[52]</xref>.</p>
<p>A Cochrane meta-analysis of ten RCTs involving 2,059 participants found a reduction in death or dependence from the neurosurgical evacuation of spontaneous supratentorial ICH (odds ratio [OR] 0.71, 95% confidence interval [CI] 0.58 to 0.88) <xref ref-type="bibr" rid="pmed.1000353-Prasad1">[53]</xref>. However, most of the RCTs included in this meta-analysis were of modest quality, their methods differed, and the largest RCT (Surgical Trial in Intracerebral Hemorrhage [STICH]) found no difference between early surgery or initial conservative management <xref ref-type="bibr" rid="pmed.1000353-Mendelow1">[54]</xref>. A sub-group with lobar ICH within 1 cm of the cortical surface appeared to benefit from surgery in STICH, so the STICH II RCT (ISRCTN 22153967) is evaluating early ICH evacuation in this sub-group of patients.</p>
<p>Secondary prevention with anti-hypertensive drugs reduced the risk of vascular events after stroke in the PROGRESS RCT; amongst the subset of 611 participants with ICH, the risk of subsequent stroke was halved by a perindopril-based blood pressure lowering regimen <xref ref-type="bibr" rid="pmed.1000353-Chapman1">[55]</xref>.</p>
</sec><sec id="s5">
<title>Treatments Neither Shown to be Beneficial to Humans in a Meta-Analysis of RCTs, Nor in a Single Large RCT</title>
<p>Haemostatic drugs are a biologically plausible intervention to improve outcome after ICH by limiting the early growth of spontaneous ICH (<xref ref-type="fig" rid="pmed-1000353-g002">Figure 2</xref>). Despite the ability of recombinant activated factor VII (rFVIIa) to curtail early haematoma growth by 4–6 ml, a Cochrane meta-analysis of four RCTs involving 1,305 participants found that this surrogate outcome did not translate into any net clinical benefit (risk ratio of death or dependence [modified Rankin Scale score 4 to 6] at 90 days = 0.91 [95% CI 0.72 to 1.15]). This reduction in ICH growth may have been too small to improve clinical outcome, its benefit may have been offset by the thrombo-embolic adverse effects of rFVIIa, or the RCTs might have been unable to detect a small benefit of rFVIIa because of insufficient precision or some methodological weaknesses <xref ref-type="bibr" rid="pmed.1000353-AlShahiSalman1">[56]</xref>. Other haemostatic drugs including antifibrinolytic agents seem to be worth testing in future RCTs.</p>
<p>Similarly, early blood pressure lowering might improve outcome after ICH by limiting the early growth of spontaneous ICH, but there has been a shortage of evidence supporting this intervention, unsurprisingly leading to differences between ICH guidelines <xref ref-type="bibr" rid="pmed.1000353-Broderick1">[9]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Steiner1">[57]</xref>. The Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT) randomized 404 patients presenting within 6 hours of onset to a systolic blood pressure target of ≤140 mmHg achieved within 1 hour and continued for 7 days, versus the American Heart Association guideline's target <xref ref-type="bibr" rid="pmed.1000353-Broderick1">[9]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Anderson1">[58]</xref>. There was a non-significant reduction in ICH growth by 1–2 ml, and no effect on clinical outcome, but the safety data are encouraging for the large, ongoing Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT-2; ISRCTN 73916115).</p>
<p>Attenuating peri-haematomal oedema might improve outcome after ICH (<xref ref-type="fig" rid="pmed-1000353-g001">Figure 1</xref>), but meta-analyses have demonstrated neither benefit nor harm from dexamethasone (five RCTs involving 206 participants) <xref ref-type="bibr" rid="pmed.1000353-Feigin2">[59]</xref>, glycerol (two RCTs involving 224 participants) <xref ref-type="bibr" rid="pmed.1000353-Righetti1">[60]</xref>, and mannitol (two RCTs involving 149 participants) <xref ref-type="bibr" rid="pmed.1000353-Bereczki1">[61]</xref>. Neuroprotection, too, has caused neither benefit nor harm after acute ICH with the anti-oxidant free-radical scavenger NXY-059 (one RCT involving 607 participants) <xref ref-type="bibr" rid="pmed.1000353-Lyden1">[62]</xref> or the glycine antagonist gavestinel (one RCT involving 571 participants) <xref ref-type="bibr" rid="pmed.1000353-Haley1">[63]</xref>.</p>
</sec><sec id="s6">
<title>Future Directions</title>
<sec id="s6a">
<title>Attenuation of Haematoma Growth</title>
<p>The major treatment target of ongoing RCTs is haematoma growth, because ICH size and growth are determinants of outcome <xref ref-type="bibr" rid="pmed.1000353-Davis1">[12]</xref>,. So far, the attenuation of early ICH growth seen with the haemostatic agent rFVIIa <xref ref-type="bibr" rid="pmed.1000353-AlShahiSalman1">[56]</xref> or intensive acute blood pressure lowering <xref ref-type="bibr" rid="pmed.1000353-Anderson1">[58]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Geeganage1">[64]</xref> has not improved clinical outcome in the RCTs performed. However, this biologically plausible mechanism for improving outcome is worthy of further research in RCTs that are large enough to detect small clinical benefits, such as the ongoing RCTs of acute blood pressure lowering (including INTERACT-2, the Efficacy of Nitric Oxide in Stroke Trial [ENOS; ISRCTN 99414122], Antihypertensive Treatment of Acute Cerebral Hemorrhage II [ATACH-II; ISRCTN R01-NS044976], and the Scandinavian Candesartan Acute Stroke Trial [SCAST; ISRCTN 13643354]). RCTs of alternative approaches to improve outcome after primary ICH by limiting haematoma expansion include rFVIIa in sub-groups of patients whose haematomas are more likely to grow (The Spot Sign for Predicting and Treating ICH Growth Study [STOP-IT; NCT00810888]), or testing the effectiveness of antifibrinolytic drugs such as the lysine analogue tranexamic acid, which seems to have attenuated ICH growth in two non-randomised studies <xref ref-type="bibr" rid="pmed.1000353-Sorimachi1">[65]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Ojacastro1">[66]</xref>.</p>
<p>The greater risk of haematoma expansion and death after ICH associated with warfarin <xref ref-type="bibr" rid="pmed.1000353-Cucchiara1">[67]</xref> and the contemporary increase in the incidence of primary ICH associated with all antithrombotic drugs <xref ref-type="bibr" rid="pmed.1000353-Lovelock1">[1]</xref> make RCTs of the management of antithrombotic-associated ICH a priority. Whilst stopping warfarin after ICH is common sense, and intravenous vitamin K administration is standard practice, there is a shortage of evidence about how else to treat anticoagulant-associated ICH <xref ref-type="bibr" rid="pmed.1000353-Aguilar1">[68]</xref>, so RCTs comparing prothrombin complex concentrate with fresh frozen plasma in this context are ongoing (International Normalized Ratio (INR) Normalization in Coumadin Associated Intracerebral Haemorrhage [INCH; NCT00928915] and Efficacy and Safety of BERIPLEX P/N Compared with Plasma in Patients with Acute Major Bleeding Caused by Anticoagulant Therapy [NCT00708435]), as are studies of rFVIIa. The finding that mortality is higher for patients who were on antiplatelet agents at the time of ICH compared to those who were not <xref ref-type="bibr" rid="pmed.1000353-Thompson1">[69]</xref> has led to an ongoing RCT of platelet transfusion to limit ICH growth and improve outcome after ICH associated with antiplatelet drugs (Platelet Transfusion in Cerebral Haemorrhage [PATCH; <ext-link ext-link-type="uri" xlink:href="http://www.strokecenter.org/trials/TrialDetail.aspx?tid=730" xlink:type="simple">http://www.strokecenter.org/trials/TrialDetail.aspx?tid=730</ext-link>).</p>
</sec><sec id="s6b">
<title>Other Approaches</title>
<p>Firstly, targeting other potentially treatable determinants of poor outcome after ICH may be fruitful. Intraventricular extension of ICH is one such mechanism <xref ref-type="bibr" rid="pmed.1000353-Qureshi1">[10]</xref>, and there are two RCTs of ventricular drainage combined with intraventricular recombinant tissue plasminogen activator (Dutch Intraventricular Thrombolysis after Cerebral Haemorrhage Study [DITCH; ISRCTN 19105863] and Clot Lysis: Evaluation Acceleration of Resolution of IVH [CLEAR-IVH; NCT00650858]).</p>
<p>Secondly, just as the PATCH RCT is a response to the apparent rise in incidence of antiplatelet-associated ICH, the apparent rise in the incidence of lobar ICH that may be caused by cerebral amyloid angiopathy merits consideration of treatments that might reduce amyloid deposition <xref ref-type="bibr" rid="pmed.1000353-Lovelock1">[1]</xref>. Tramiprosate is a synthetic compound that competes with glycosaminoglycans for binding to β-amyloid peptide, reducing amyloid fibril formation and deposition, and demonstrated a good safety profile in a phase II study <xref ref-type="bibr" rid="pmed.1000353-Greenberg1">[70]</xref>. Amyloid-depleting agents, which have shown remarkable effects in Alzheimer's disease <xref ref-type="bibr" rid="pmed.1000353-Kolstoe1">[71]</xref>, are an alternative approach and may be preferable to amyloid-β immunisation, which can induce an immune-mediated encephalomyelitis <xref ref-type="bibr" rid="pmed.1000353-Orgogozo1">[72]</xref>.</p>
<p>Lastly, treatments that have proven beneficial in animal models might translate from the bench to the bedside, although there are concerns about the rodent ICH models used and the methodological quality of animal experiments <xref ref-type="bibr" rid="pmed.1000353-James1">[45]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Andaluz1">[46]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Frantzias1">[73]</xref>. One such example is deferoxamine (an iron-chelating agent that crosses the blood–brain barrier, and has been associated with a reduction in brain oedema, neurological deficits, and biochemical markers of oxidative damage in animals) <xref ref-type="bibr" rid="pmed.1000353-Nakamura1">[74]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Gu1">[75]</xref>, which has led to the Dose Finding and Safety study of Deferoxamine in Patients with Brain Hemorrhage (DFO in ICH; NCT00598572).</p>
</sec></sec><sec id="s7">
<title>Conclusions</title>
<p>The incidence and risk of dying from ICH seem not to have changed in recent decades, whilst the incidence of ischaemic stroke has declined <xref ref-type="bibr" rid="pmed.1000353-vanAsch1">[2]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Feigin1">[3]</xref>. In contrast to the advances in the treatment of ischaemic stroke, stroke unit care and secondary prevention with blood pressure reduction are the only interventions for patients with stroke due to ICH that are based on robust evidence <xref ref-type="bibr" rid="pmed.1000353-Stroke1">[47]</xref>,<xref ref-type="bibr" rid="pmed.1000353-Chapman1">[55]</xref>. However, insights gleaned from radiological and pathological investigations of the cause and pathophysiology of ICH, and the relentless pursuit of potential treatments in ongoing RCTs, are all cause for optimism <xref ref-type="bibr" rid="pmed.1000353-NINDS1">[76]</xref>.</p>
<boxed-text id="pmed-1000353-box002" position="float"><sec id="s7a1">
<title>Five Key Papers in the Field</title>
<list list-type="bullet"><list-item>
<p>van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, et al. (2010) Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 9(2): 167–176.</p>
</list-item><list-item>
<p>Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, et al. (2006) Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 66(8): 1175–1181.</p>
</list-item><list-item>
<p>Stroke Unit Trialists' Collaboration (2007) Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev (4): CD000197.</p>
</list-item><list-item>
<p>Chapman N, Huxley R, Anderson C, Bousser MG, Chalmers J, et al. (2004) Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. Stroke 35(1): 116–121.</p>
</list-item><list-item>
<p>NINDS ICH Workshop Participants (2005) Priorities for clinical research in intracerebral hemorrhage: report from a National Institute of Neurological Disorders and Stroke workshop. Stroke 36(3): e23–e41.</p>
</list-item></list>
</sec></boxed-text></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pmed.1000353-Lovelock1"><label>1</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lovelock</surname><given-names>CE</given-names></name>
<name name-style="western"><surname>Molyneux</surname><given-names>AJ</given-names></name>
<name name-style="western"><surname>Rothwell</surname><given-names>PM</given-names></name>
</person-group>             <year>2007</year>             <article-title>Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study.</article-title>             <source>Lancet Neurol</source>             <volume>6</volume>             <fpage>487</fpage>             <lpage>493</lpage>          </element-citation></ref>
<ref id="pmed.1000353-vanAsch1"><label>2</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>van Asch</surname><given-names>CJ</given-names></name>
<name name-style="western"><surname>Luitse</surname><given-names>MJ</given-names></name>
<name name-style="western"><surname>Rinkel</surname><given-names>GJ</given-names></name>
<name name-style="western"><surname>van der Tweel</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Algra</surname><given-names>A</given-names></name>
<etal/></person-group>             <year>2010</year>             <article-title>Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis.</article-title>             <source>Lancet Neurol</source>             <volume>9</volume>             <fpage>167</fpage>             <lpage>176</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Feigin1"><label>3</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Feigin</surname><given-names>VL</given-names></name>
<name name-style="western"><surname>Lawes</surname><given-names>CM</given-names></name>
<name name-style="western"><surname>Bennett</surname><given-names>DA</given-names></name>
<name name-style="western"><surname>Barker-Collo</surname><given-names>SL</given-names></name>
<name name-style="western"><surname>Parag</surname><given-names>V</given-names></name>
</person-group>             <year>2009</year>             <article-title>Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review.</article-title>             <source>Lancet Neurol</source>             <volume>8</volume>             <fpage>355</fpage>             <lpage>369</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Ariesen1"><label>4</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ariesen</surname><given-names>MJ</given-names></name>
<name name-style="western"><surname>Claus</surname><given-names>SP</given-names></name>
<name name-style="western"><surname>Rinkel</surname><given-names>GJ</given-names></name>
<name name-style="western"><surname>Algra</surname><given-names>A</given-names></name>
</person-group>             <year>2003</year>             <article-title>Risk factors for intracerebral hemorrhage in the general population: a systematic review.</article-title>             <source>Stroke</source>             <volume>34</volume>             <fpage>2060</fpage>             <lpage>2065</lpage>          </element-citation></ref>
<ref id="pmed.1000353-vanBeijnum1"><label>5</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>van Beijnum</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Lovelock</surname><given-names>CE</given-names></name>
<name name-style="western"><surname>Cordonnier</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Rothwell</surname><given-names>PM</given-names></name>
<name name-style="western"><surname>Klijn</surname><given-names>CJ</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies.</article-title>             <source>Brain</source>             <volume>132</volume>             <fpage>537</fpage>             <lpage>543</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Cordonnier1"><label>6</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cordonnier</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Klijn</surname><given-names>CJ</given-names></name>
<name name-style="western"><surname>van Beijnum</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Al-Shahi Salman</surname><given-names>R</given-names></name>
</person-group>             <year>2010</year>             <article-title>Radiological investigation of spontaneous intracerebral hemorrhage: systematic review and trinational survey.</article-title>             <source>Stroke</source>             <volume>41</volume>             <fpage>685</fpage>             <lpage>690</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Ritter1"><label>7</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ritter</surname><given-names>MA</given-names></name>
<name name-style="western"><surname>Droste</surname><given-names>DW</given-names></name>
<name name-style="western"><surname>Hegedus</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Szepesi</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Nabavi</surname><given-names>DG</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Role of cerebral amyloid angiopathy in intracerebral hemorrhage in hypertensive patients.</article-title>             <source>Neurology</source>             <volume>64</volume>             <fpage>1233</fpage>             <lpage>1237</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Jackson1"><label>8</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Jackson</surname><given-names>CA</given-names></name>
<name name-style="western"><surname>Sudlow</surname><given-names>CL</given-names></name>
</person-group>             <year>2006</year>             <article-title>Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage?</article-title>             <source>J Neurol Neurosurg Psychiatry</source>             <volume>77</volume>             <fpage>1244</fpage>             <lpage>1252</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Broderick1"><label>9</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Broderick</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Connolly</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Feldmann</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Hanley</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Kase</surname><given-names>C</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group.</article-title>             <source>Stroke</source>             <volume>38</volume>             <fpage>2001</fpage>             <lpage>2023</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Qureshi1"><label>10</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Qureshi</surname><given-names>AI</given-names></name>
<name name-style="western"><surname>Mendelow</surname><given-names>AD</given-names></name>
<name name-style="western"><surname>Hanley</surname><given-names>DF</given-names></name>
</person-group>             <year>2009</year>             <article-title>Intracerebral haemorrhage.</article-title>             <source>Lancet</source>             <volume>373</volume>             <fpage>1632</fpage>             <lpage>1644</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Brott1"><label>11</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Brott</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Broderick</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Kothari</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Barsan</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Tomsick</surname><given-names>T</given-names></name>
<etal/></person-group>             <year>1997</year>             <article-title>Early hemorrhage growth in patients with intracerebral hemorrhage.</article-title>             <source>Stroke</source>             <volume>28</volume>             <fpage>1</fpage>             <lpage>5</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Davis1"><label>12</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Davis</surname><given-names>SM</given-names></name>
<name name-style="western"><surname>Broderick</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Hennerici</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Brun</surname><given-names>NC</given-names></name>
<name name-style="western"><surname>Diringer</surname><given-names>MN</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.</article-title>             <source>Neurology</source>             <volume>66</volume>             <fpage>1175</fpage>             <lpage>1181</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Ji1"><label>13</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ji</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Lu</surname><given-names>JJ</given-names></name>
<name name-style="western"><surname>Zhao</surname><given-names>YL</given-names></name>
<name name-style="western"><surname>Wang</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Zhao</surname><given-names>JZ</given-names></name>
</person-group>             <year>2009</year>             <article-title>Imaging and clinical prognostic indicators for early hematoma enlargement after spontaneous intracerebral hemorrhage.</article-title>             <source>Neurol Res</source>             <volume>31</volume>             <fpage>362</fpage>             <lpage>366</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Fujitsu1"><label>14</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Fujitsu</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Muramoto</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Ikeda</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Inada</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Kim</surname><given-names>I</given-names></name>
<etal/></person-group>             <year>1990</year>             <article-title>Indications for surgical treatment of putaminal hemorrhage. Comparative study based on serial CT and time-course analysis.</article-title>             <source>J Neurosurg</source>             <volume>73</volume>             <fpage>518</fpage>             <lpage>525</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Sansing1"><label>15</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Sansing</surname><given-names>LH</given-names></name>
<name name-style="western"><surname>Messe</surname><given-names>SR</given-names></name>
<name name-style="western"><surname>Cucchiara</surname><given-names>BL</given-names></name>
<name name-style="western"><surname>Cohen</surname><given-names>SN</given-names></name>
<name name-style="western"><surname>Lyden</surname><given-names>PD</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH.</article-title>             <source>Neurology</source>             <volume>72</volume>             <fpage>1397</fpage>             <lpage>1402</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Leira1"><label>16</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Leira</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Davalos</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Silva</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Gil-Peralta</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Tejada</surname><given-names>J</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors.</article-title>             <source>Neurology</source>             <volume>63</volume>             <fpage>461</fpage>             <lpage>467</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Fujii1"><label>17</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Fujii</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Takeuchi</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Sasaki</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Minakawa</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Tanaka</surname><given-names>R</given-names></name>
</person-group>             <year>1998</year>             <article-title>Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage.</article-title>             <source>Stroke</source>             <volume>29</volume>             <fpage>1160</fpage>             <lpage>1166</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Kazui1"><label>18</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kazui</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Naritomi</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Yamamoto</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Sawada</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Yamaguchi</surname><given-names>T</given-names></name>
</person-group>             <year>1996</year>             <article-title>Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course.</article-title>             <source>Stroke</source>             <volume>27</volume>             <fpage>1783</fpage>             <lpage>1787</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Kazui2"><label>19</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kazui</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Minematsu</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Yamamoto</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Sawada</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Yamaguchi</surname><given-names>T</given-names></name>
</person-group>             <year>1997</year>             <article-title>Predisposing factors to enlargement of spontaneous intracerebral hematoma.</article-title>             <source>Stroke</source>             <volume>28</volume>             <fpage>2370</fpage>             <lpage>2375</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Ohwaki1"><label>20</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ohwaki</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Yano</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Nagashima</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Hirata</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Nakagomi</surname><given-names>T</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement.</article-title>             <source>Stroke</source>             <volume>35</volume>             <fpage>1364</fpage>             <lpage>1367</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Flibotte1"><label>21</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Flibotte</surname><given-names>JJ</given-names></name>
<name name-style="western"><surname>Hagan</surname><given-names>N</given-names></name>
<name name-style="western"><surname>O'Donnell</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Greenberg</surname><given-names>SM</given-names></name>
<name name-style="western"><surname>Rosand</surname><given-names>J</given-names></name>
</person-group>             <year>2004</year>             <article-title>Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage.</article-title>             <source>Neurology</source>             <volume>63</volume>             <fpage>1059</fpage>             <lpage>1064</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Hemphill1"><label>22</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hemphill</surname><given-names>JC</given-names><suffix>III</suffix></name>
<name name-style="western"><surname>Bonovich</surname><given-names>DC</given-names></name>
<name name-style="western"><surname>Besmertis</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Manley</surname><given-names>GT</given-names></name>
<name name-style="western"><surname>Johnston</surname><given-names>SC</given-names></name>
</person-group>             <year>2001</year>             <article-title>The ICH score: a simple, reliable grading scale for intracerebral hemorrhage.</article-title>             <source>Stroke</source>             <volume>32</volume>             <fpage>891</fpage>             <lpage>897</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Rosand1"><label>23</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Rosand</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Eskey</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Chang</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Gonzalez</surname><given-names>RG</given-names></name>
<name name-style="western"><surname>Greenberg</surname><given-names>SM</given-names></name>
<etal/></person-group>             <year>2002</year>             <article-title>Dynamic single-section CT demonstrates reduced cerebral blood flow in acute intracerebral hemorrhage.</article-title>             <source>Cerebrovasc Dis</source>             <volume>14</volume>             <fpage>214</fpage>             <lpage>220</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Pascual1"><label>24</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Pascual</surname><given-names>AM</given-names></name>
<name name-style="western"><surname>Lopez-Mut</surname><given-names>JV</given-names></name>
<name name-style="western"><surname>Benlloch</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Chamarro</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Soler</surname><given-names>J</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Perfusion-weighted magnetic resonance imaging in acute intracerebral hemorrhage at baseline and during the 1st and 2nd week: a longitudinal study.</article-title>             <source>Cerebrovasc Dis</source>             <volume>23</volume>             <fpage>6</fpage>             <lpage>13</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Zazulia1"><label>25</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Zazulia</surname><given-names>AR</given-names></name>
<name name-style="western"><surname>Diringer</surname><given-names>MN</given-names></name>
<name name-style="western"><surname>Videen</surname><given-names>TO</given-names></name>
<name name-style="western"><surname>Adams</surname><given-names>RE</given-names></name>
<name name-style="western"><surname>Yundt</surname><given-names>K</given-names></name>
<etal/></person-group>             <year>2001</year>             <article-title>Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage.</article-title>             <source>J Cereb Blood Flow Metab</source>             <volume>21</volume>             <fpage>804</fpage>             <lpage>810</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Herweh1"><label>26</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Herweh</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Juttler</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Schellinger</surname><given-names>PD</given-names></name>
<name name-style="western"><surname>Klotz</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Jenetzky</surname><given-names>E</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Evidence against a perihemorrhagic penumbra provided by perfusion computed tomography.</article-title>             <source>Stroke</source>             <volume>38</volume>             <fpage>2941</fpage>             <lpage>2947</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Zazulia2"><label>27</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Zazulia</surname><given-names>AR</given-names></name>
<name name-style="western"><surname>Videen</surname><given-names>TO</given-names></name>
<name name-style="western"><surname>Powers</surname><given-names>WJ</given-names></name>
</person-group>             <year>2009</year>             <article-title>Transient focal increase in perihematomal glucose metabolism after acute human intracerebral hemorrhage.</article-title>             <source>Stroke</source>             <volume>40</volume>             <fpage>1638</fpage>             <lpage>1643</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Butcher1"><label>28</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Butcher</surname><given-names>KS</given-names></name>
<name name-style="western"><surname>Baird</surname><given-names>T</given-names></name>
<name name-style="western"><surname>MacGregor</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Desmond</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Tress</surname><given-names>B</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>Perihematomal edema in primary intracerebral hemorrhage is plasma derived.</article-title>             <source>Stroke</source>             <volume>35</volume>             <fpage>1879</fpage>             <lpage>1885</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Zazulia3"><label>29</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Zazulia</surname><given-names>AR</given-names></name>
<name name-style="western"><surname>Diringer</surname><given-names>MN</given-names></name>
<name name-style="western"><surname>Derdeyn</surname><given-names>CP</given-names></name>
<name name-style="western"><surname>Powers</surname><given-names>WJ</given-names></name>
</person-group>             <year>1999</year>             <article-title>Progression of mass effect after intracerebral hemorrhage.</article-title>             <source>Stroke</source>             <volume>30</volume>             <fpage>1167</fpage>             <lpage>1173</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Gebel1"><label>30</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Gebel</surname><given-names>JM</given-names><suffix>Jr</suffix></name>
<name name-style="western"><surname>Jauch</surname><given-names>EC</given-names></name>
<name name-style="western"><surname>Brott</surname><given-names>TG</given-names></name>
<name name-style="western"><surname>Khoury</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Sauerbeck</surname><given-names>L</given-names></name>
<etal/></person-group>             <year>2002</year>             <article-title>Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage.</article-title>             <source>Stroke</source>             <volume>33</volume>             <fpage>2631</fpage>             <lpage>2635</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Inaji1"><label>31</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Inaji</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Tomita</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Tone</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Tamaki</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Suzuki</surname><given-names>R</given-names></name>
<etal/></person-group>             <year>2003</year>             <article-title>Chronological changes of perihematomal edema of human intracerebral hematoma.</article-title>             <source>Acta Neurochir Suppl</source>             <volume>86</volume>             <fpage>445</fpage>             <lpage>8</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Gebel2"><label>32</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Gebel</surname><given-names>JM</given-names></name>
<name name-style="western"><surname>Brott</surname><given-names>TG</given-names></name>
<name name-style="western"><surname>Sila</surname><given-names>CA</given-names></name>
<name name-style="western"><surname>Tomsick</surname><given-names>TA</given-names></name>
<name name-style="western"><surname>Jauch</surname><given-names>E</given-names></name>
<etal/></person-group>             <year>2000</year>             <article-title>Decreased perihematomal edema in thrombolysis-related intracerebral hemorrhage compared with spontaneous intracerebral hemorrhage.</article-title>             <source>Stroke</source>             <volume>31</volume>             <fpage>596</fpage>             <lpage>600</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Sansing2"><label>33</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Sansing</surname><given-names>LH</given-names></name>
<name name-style="western"><surname>Kaznatcheeva</surname><given-names>EA</given-names></name>
<name name-style="western"><surname>Perkins</surname><given-names>CJ</given-names></name>
<name name-style="western"><surname>Komaroff</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Gutman</surname><given-names>FB</given-names></name>
<etal/></person-group>             <year>2003</year>             <article-title>Edema after intracerebral hemorrhage: correlations with coagulation parameters and treatment.</article-title>             <source>J Neurosurg</source>             <volume>98</volume>             <fpage>985</fpage>             <lpage>992</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Wagner1"><label>34</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Wagner</surname><given-names>KR</given-names></name>
<name name-style="western"><surname>Xi</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Hua</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Kleinholz</surname><given-names>M</given-names></name>
<name name-style="western"><surname>de Court</surname></name>
<etal/></person-group>             <year>1996</year>             <article-title>Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter.</article-title>             <source>Stroke</source>             <volume>27</volume>             <fpage>490</fpage>             <lpage>497</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Lee1"><label>35</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lee</surname><given-names>KR</given-names></name>
<name name-style="western"><surname>Kawai</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Kim</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Sagher</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Hoff</surname><given-names>JT</given-names></name>
</person-group>             <year>1997</year>             <article-title>Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model.</article-title>             <source>J Neurosurg</source>             <volume>86</volume>             <fpage>272</fpage>             <lpage>278</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Huang1"><label>36</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Huang</surname><given-names>FP</given-names></name>
<name name-style="western"><surname>Xi</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Keep</surname><given-names>RF</given-names></name>
<name name-style="western"><surname>Hua</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Nemoianu</surname><given-names>A</given-names></name>
<etal/></person-group>             <year>2002</year>             <article-title>Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products.</article-title>             <source>J Neurosurg</source>             <volume>96</volume>             <fpage>287</fpage>             <lpage>293</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Levine1"><label>37</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Levine</surname><given-names>JM</given-names></name>
<name name-style="western"><surname>Snider</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Finkelstein</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Gurol</surname><given-names>ME</given-names></name>
<name name-style="western"><surname>Chanderraj</surname><given-names>R</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Early edema in warfarin-related intracerebral hemorrhage.</article-title>             <source>Neurocrit Care</source>             <volume>7</volume>             <fpage>58</fpage>             <lpage>63</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Weiss1"><label>38</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Weiss</surname><given-names>SJ</given-names></name>
</person-group>             <year>1989</year>             <article-title>Tissue destruction by neutrophils.</article-title>             <source>N Engl J Med</source>             <volume>320</volume>             <fpage>365</fpage>             <lpage>376</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Power1"><label>39</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Power</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Henry</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Del Bigio</surname><given-names>MR</given-names></name>
<name name-style="western"><surname>Larsen</surname><given-names>PH</given-names></name>
<name name-style="western"><surname>Corbett</surname><given-names>D</given-names></name>
<etal/></person-group>             <year>2003</year>             <article-title>Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases.</article-title>             <source>Ann Neurol</source>             <volume>53</volume>             <fpage>731</fpage>             <lpage>742</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Mayne1"><label>40</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Mayne</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Ni</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Yan</surname><given-names>HJ</given-names></name>
<name name-style="western"><surname>Xue</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Johnston</surname><given-names>JB</given-names></name>
<etal/></person-group>             <year>2001</year>             <article-title>Antisense oligodeoxynucleotide inhibition of tumor necrosis factor-alpha expression is neuroprotective after intracerebral hemorrhage.</article-title>             <source>Stroke</source>             <volume>32</volume>             <fpage>240</fpage>             <lpage>248</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Holmin1"><label>41</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Holmin</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Mathiesen</surname><given-names>T</given-names></name>
</person-group>             <year>2000</year>             <article-title>Intracerebral administration of interleukin-1beta and induction of inflammation, apoptosis, and vasogenic edema.</article-title>             <source>J Neurosurg</source>             <volume>92</volume>             <fpage>108</fpage>             <lpage>120</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Xi1"><label>42</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Xi</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Hua</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Keep</surname><given-names>RF</given-names></name>
<name name-style="western"><surname>Younger</surname><given-names>JG</given-names></name>
<name name-style="western"><surname>Hoff</surname><given-names>JT</given-names></name>
</person-group>             <year>2001</year>             <article-title>Systemic complement depletion diminishes perihematomal brain edema in rats.</article-title>             <source>Stroke</source>             <volume>32</volume>             <fpage>162</fpage>             <lpage>167</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Wang1"><label>43</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Tsirka</surname><given-names>SE</given-names></name>
</person-group>             <year>2005</year>             <article-title>Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage.</article-title>             <source>Brain</source>             <volume>128</volume>             <fpage>1622</fpage>             <lpage>1633</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Ayoub1"><label>44</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ayoub</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Chow</surname><given-names>J</given-names></name>
</person-group>             <year>2008</year>             <article-title>The conventional autopsy in modern medicine.</article-title>             <source>J R Soc Med</source>             <volume>101</volume>             <fpage>177</fpage>             <lpage>181</lpage>          </element-citation></ref>
<ref id="pmed.1000353-James1"><label>45</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>James</surname><given-names>ML</given-names></name>
<name name-style="western"><surname>Warner</surname><given-names>DS</given-names></name>
<name name-style="western"><surname>Laskowitz</surname><given-names>DT</given-names></name>
</person-group>             <year>2008</year>             <article-title>Preclinical models of intracerebral hemorrhage: a translational perspective.</article-title>             <source>Neurocrit Care</source>             <volume>9</volume>             <fpage>139</fpage>             <lpage>152</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Andaluz1"><label>46</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Andaluz</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Zuccarello</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Wagner</surname><given-names>KR</given-names></name>
</person-group>             <year>2002</year>             <article-title>Experimental animal models of intracerebral hemorrhage.</article-title>             <source>Neurosurg Clin N Am</source>             <volume>13</volume>             <fpage>385</fpage>             <lpage>393</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Stroke1"><label>47</label><element-citation publication-type="journal" xlink:type="simple">             <collab xlink:type="simple">Stroke Unit Trialists' Collaboration</collab>             <year>2007</year>             <article-title>Organised inpatient (stroke unit) care for stroke.</article-title>             <source>Cochrane Database Syst Rev</source>             <volume>CD000197</volume>          </element-citation></ref>
<ref id="pmed.1000353-Candelise1"><label>48</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Candelise</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Gattinoni</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Bersano</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Micieli</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Sterzi</surname><given-names>R</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Stroke-unit care for acute stroke patients: an observational follow-up study.</article-title>             <source>Lancet</source>             <volume>369</volume>             <fpage>299</fpage>             <lpage>305</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Terent1"><label>49</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Terent</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Asplund</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Farahmand</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Henriksson</surname><given-names>KM</given-names></name>
<name name-style="western"><surname>Norrving</surname><given-names>B</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Stroke unit care revisited: who benefits the most? A cohort study of 105,043 patients in Riks-Stroke, the Swedish Stroke Register.</article-title>             <source>J Neurol Neurosurg Psychiatry</source>             <volume>80</volume>             <fpage>881</fpage>             <lpage>887</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Diringer1"><label>50</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Diringer</surname><given-names>MN</given-names></name>
<name name-style="western"><surname>Edwards</surname><given-names>DF</given-names></name>
</person-group>             <year>2001</year>             <article-title>Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage.</article-title>             <source>Crit Care Med</source>             <volume>29</volume>             <fpage>635</fpage>             <lpage>640</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Hemphill2"><label>51</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hemphill</surname><given-names>JC</given-names><suffix>III</suffix></name>
<name name-style="western"><surname>Newman</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Zhao</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Johnston</surname><given-names>SC</given-names></name>
</person-group>             <year>2004</year>             <article-title>Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage.</article-title>             <source>Stroke</source>             <volume>35</volume>             <fpage>1130</fpage>             <lpage>1134</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Becker1"><label>52</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Becker</surname><given-names>KJ</given-names></name>
<name name-style="western"><surname>Baxter</surname><given-names>AB</given-names></name>
<name name-style="western"><surname>Cohen</surname><given-names>WA</given-names></name>
<name name-style="western"><surname>Bybee</surname><given-names>HM</given-names></name>
<name name-style="western"><surname>Tirschwell</surname><given-names>DL</given-names></name>
<etal/></person-group>             <year>2001</year>             <article-title>Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies.</article-title>             <source>Neurology</source>             <volume>56</volume>             <fpage>766</fpage>             <lpage>772</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Prasad1"><label>53</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Prasad</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Mendelow</surname><given-names>AD</given-names></name>
<name name-style="western"><surname>Gregson</surname><given-names>B</given-names></name>
</person-group>             <year>2008</year>             <article-title>Surgery for primary supratentorial intracerebral haemorrhage.</article-title>             <source>Cochrane Database Syst Rev</source>             <volume>CD000200</volume>          </element-citation></ref>
<ref id="pmed.1000353-Mendelow1"><label>54</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Mendelow</surname><given-names>AD</given-names></name>
<name name-style="western"><surname>Gregson</surname><given-names>BA</given-names></name>
<name name-style="western"><surname>Fernandes</surname><given-names>HM</given-names></name>
<name name-style="western"><surname>Murray</surname><given-names>GD</given-names></name>
<name name-style="western"><surname>Teasdale</surname><given-names>GM</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial.</article-title>             <source>Lancet</source>             <volume>365</volume>             <fpage>387</fpage>             <lpage>397</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Chapman1"><label>55</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Chapman</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Huxley</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Anderson</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Bousser</surname><given-names>MG</given-names></name>
<name name-style="western"><surname>Chalmers</surname><given-names>J</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.</article-title>             <source>Stroke</source>             <volume>35</volume>             <fpage>116</fpage>             <lpage>121</lpage>          </element-citation></ref>
<ref id="pmed.1000353-AlShahiSalman1"><label>56</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Al-Shahi Salman</surname><given-names>R</given-names></name>
</person-group>             <year>2009</year>             <article-title>Haemostatic drug therapies for acute spontaneous intracerebral haemorrhage.</article-title>             <source>Cochrane Database Syst Rev</source>             <volume>CD005951</volume>          </element-citation></ref>
<ref id="pmed.1000353-Steiner1"><label>57</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Steiner</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Kaste</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Forsting</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Mendelow</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Kwiecinski</surname><given-names>H</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee.</article-title>             <source>Cerebrovasc Dis</source>             <volume>22</volume>             <fpage>294</fpage>             <lpage>316</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Anderson1"><label>58</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Anderson</surname><given-names>CS</given-names></name>
<name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Wang</surname><given-names>JG</given-names></name>
<name name-style="western"><surname>Arima</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Neal</surname><given-names>B</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial.</article-title>             <source>Lancet Neurol</source>             <volume>7</volume>             <fpage>391</fpage>             <lpage>399</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Feigin2"><label>59</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Feigin</surname><given-names>VL</given-names></name>
<name name-style="western"><surname>Anderson</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Rinkel</surname><given-names>GJ</given-names></name>
<name name-style="western"><surname>Algra</surname><given-names>A</given-names></name>
<name name-style="western"><surname>van</surname><given-names>GJ</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage.</article-title>             <source>Cochrane Database Syst Rev</source>             <volume>CD004583</volume>          </element-citation></ref>
<ref id="pmed.1000353-Righetti1"><label>60</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Righetti</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Celani</surname><given-names>MG</given-names></name>
<name name-style="western"><surname>Cantisani</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Sterzi</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Boysen</surname><given-names>G</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>Glycerol for acute stroke.</article-title>             <source>Cochrane Database Syst Rev</source>             <volume>CD000096</volume>          </element-citation></ref>
<ref id="pmed.1000353-Bereczki1"><label>61</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Bereczki</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Fekete</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Prado</surname><given-names>GF</given-names></name>
<name name-style="western"><surname>Liu</surname><given-names>M</given-names></name>
</person-group>             <year>2007</year>             <article-title>Mannitol for acute stroke.</article-title>             <source>Cochrane Database Syst Rev</source>             <volume>CD001153</volume>          </element-citation></ref>
<ref id="pmed.1000353-Lyden1"><label>62</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lyden</surname><given-names>PD</given-names></name>
<name name-style="western"><surname>Shuaib</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Lees</surname><given-names>KR</given-names></name>
<name name-style="western"><surname>Davalos</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Davis</surname><given-names>SM</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial.</article-title>             <source>Stroke</source>             <volume>38</volume>             <fpage>2262</fpage>             <lpage>2269</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Haley1"><label>63</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Haley</surname><given-names>EC</given-names><suffix>Jr</suffix></name>
<name name-style="western"><surname>Thompson</surname><given-names>JL</given-names></name>
<name name-style="western"><surname>Levin</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Davis</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Lees</surname><given-names>KR</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Gavestinel does not improve outcome after acute intracerebral hemorrhage: an analysis from the GAIN International and GAIN Americas studies.</article-title>             <source>Stroke</source>             <volume>36</volume>             <fpage>1006</fpage>             <lpage>1010</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Geeganage1"><label>64</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Geeganage</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Bath</surname><given-names>PM</given-names></name>
</person-group>             <year>2008</year>             <article-title>Interventions for deliberately altering blood pressure in acute stroke.</article-title>             <source>Cochrane Database Syst Rev</source>             <volume>CD000039</volume>          </element-citation></ref>
<ref id="pmed.1000353-Sorimachi1"><label>65</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Sorimachi</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Fujii</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Morita</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Tanaka</surname><given-names>R</given-names></name>
</person-group>             <year>2005</year>             <article-title>Rapid administration of antifibrinolytics and strict blood pressure control for intracerebral hemorrhage.</article-title>             <source>Neurosurgery</source>             <volume>57</volume>             <fpage>837</fpage>             <lpage>844</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Ojacastro1"><label>66</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ojacastro</surname><given-names>MF</given-names></name>
<name name-style="western"><surname>Tabuena</surname><given-names>MP</given-names></name>
<name name-style="western"><surname>Dulos</surname><given-names>ID</given-names></name>
<name name-style="western"><surname>Tabuena</surname><given-names>RP</given-names></name>
</person-group>             <year>2008</year>             <article-title>Efficacy of tranexamic acid in reducing hematoma volume in patients with hypertensive intracerebral hemorrhage.</article-title>             <source>Int J Stroke</source>             <volume>3</volume>             <fpage>197</fpage>             <lpage>198 (abstract)</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Cucchiara1"><label>67</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cucchiara</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Messe</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Sansing</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Kasner</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Lyden</surname><given-names>P</given-names></name>
</person-group>             <year>2008</year>             <article-title>Hematoma growth in oral anticoagulant related intracerebral hemorrhage.</article-title>             <source>Stroke</source>             <volume>39</volume>             <fpage>2993</fpage>             <lpage>2996</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Aguilar1"><label>68</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Aguilar</surname><given-names>MI</given-names></name>
<name name-style="western"><surname>Hart</surname><given-names>RG</given-names></name>
<name name-style="western"><surname>Kase</surname><given-names>CS</given-names></name>
<name name-style="western"><surname>Freeman</surname><given-names>WD</given-names></name>
<name name-style="western"><surname>Hoeben</surname><given-names>BJ</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion.</article-title>             <source>Mayo Clin Proc</source>             <volume>82</volume>             <fpage>82</fpage>             <lpage>92</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Thompson1"><label>69</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Thompson</surname><given-names>BB</given-names></name>
<name name-style="western"><surname>Bejot</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Caso</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Castillo</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Christensen</surname><given-names>H</given-names></name>
<etal/></person-group>             <year>2010</year>             <article-title>Prior antiplatelet therapy and outcome following intracerebral hemorrhage. A systematic review.</article-title>             <source>Neurology</source>             <comment>Epub ahead of print. doi:WNL.0b013e3181f735e5v1</comment>          </element-citation></ref>
<ref id="pmed.1000353-Greenberg1"><label>70</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Greenberg</surname><given-names>SM</given-names></name>
<name name-style="western"><surname>Rosand</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Schneider</surname><given-names>AT</given-names></name>
<name name-style="western"><surname>Creed</surname><given-names>PL</given-names></name>
<name name-style="western"><surname>Gandy</surname><given-names>SE</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>A phase 2 study of tramiprosate for cerebral amyloid angiopathy.</article-title>             <source>Alzheimer Dis Assoc Disord</source>             <volume>20</volume>             <fpage>269</fpage>             <lpage>274</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Kolstoe1"><label>71</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kolstoe</surname><given-names>SE</given-names></name>
<name name-style="western"><surname>Ridha</surname><given-names>BH</given-names></name>
<name name-style="western"><surname>Bellotti</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Wang</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Robinson</surname><given-names>CV</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>106</volume>             <fpage>7619</fpage>             <lpage>7623</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Orgogozo1"><label>72</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Orgogozo</surname><given-names>JM</given-names></name>
<name name-style="western"><surname>Gilman</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Dartigues</surname><given-names>JF</given-names></name>
<name name-style="western"><surname>Laurent</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Puel</surname><given-names>M</given-names></name>
<etal/></person-group>             <year>2003</year>             <article-title>Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization.</article-title>             <source>Neurology</source>             <volume>61</volume>             <fpage>46</fpage>             <lpage>54</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Frantzias1"><label>73</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Frantzias</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Sena</surname><given-names>ES</given-names></name>
<name name-style="western"><surname>Macleod</surname><given-names>MR</given-names></name>
<name name-style="western"><surname>Al-Shahi Salman</surname><given-names>R</given-names></name>
</person-group>             <year>2010</year>             <article-title>Treatment of intracerebral hemorrhage in animal models: Meta-analysis</article-title>             <source>Ann Neurol</source>             <comment>In press</comment>          </element-citation></ref>
<ref id="pmed.1000353-Nakamura1"><label>74</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Nakamura</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Keep</surname><given-names>RF</given-names></name>
<name name-style="western"><surname>Hua</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Schallert</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Hoff</surname><given-names>JT</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage.</article-title>             <source>J Neurosurg</source>             <volume>100</volume>             <fpage>672</fpage>             <lpage>678</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Gu1"><label>75</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Gu</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Hua</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Keep</surname><given-names>RF</given-names></name>
<name name-style="western"><surname>Morgenstern</surname><given-names>LB</given-names></name>
<name name-style="western"><surname>Xi</surname><given-names>G</given-names></name>
</person-group>             <year>2009</year>             <article-title>Deferoxamine reduces intracerebral hematoma-induced iron accumulation and neuronal death in piglets.</article-title>             <source>Stroke</source>             <volume>40</volume>             <fpage>2241</fpage>             <lpage>2243</lpage>          </element-citation></ref>
<ref id="pmed.1000353-NINDS1"><label>76</label><element-citation publication-type="journal" xlink:type="simple">             <collab xlink:type="simple">NINDS ICH Workshop Participants</collab>             <year>2005</year>             <article-title>Priorities for clinical research in intracerebral hemorrhage: report from a National Institute of Neurological Disorders and Stroke workshop.</article-title>             <source>Stroke</source>             <volume>36</volume>             <fpage>e23</fpage>             <lpage>e41</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Herold1"><label>77</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Herold</surname><given-names>S</given-names></name>
<name name-style="western"><surname>von</surname><given-names>KR</given-names></name>
<name name-style="western"><surname>Jaeger</surname><given-names>C</given-names></name>
</person-group>             <year>1982</year>             <article-title>Follow-up of spontaneous intracerebral haemorrhage by computed tomography.</article-title>             <source>J Neurol</source>             <volume>228</volume>             <fpage>267</fpage>             <lpage>276</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Kelley1"><label>78</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kelley</surname><given-names>RE</given-names></name>
<name name-style="western"><surname>Berger</surname><given-names>JR</given-names></name>
<name name-style="western"><surname>Scheinberg</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Stokes</surname><given-names>N</given-names></name>
</person-group>             <year>1982</year>             <article-title>Active bleeding in hypertensive intracerebral hemorrhage: computed tomography.</article-title>             <source>Neurology</source>             <volume>32</volume>             <fpage>852</fpage>             <lpage>856</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Silva1"><label>79</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Silva</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Leira</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Tejada</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Lainez</surname><given-names>JM</given-names></name>
<name name-style="western"><surname>Castillo</surname><given-names>J</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage.</article-title>             <source>Stroke</source>             <volume>36</volume>             <fpage>86</fpage>             <lpage>91</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Jauch1"><label>80</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Jauch</surname><given-names>EC</given-names></name>
<name name-style="western"><surname>Lindsell</surname><given-names>CJ</given-names></name>
<name name-style="western"><surname>Adeoye</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Khoury</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Barsan</surname><given-names>W</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage.</article-title>             <source>Stroke</source>             <volume>37</volume>             <fpage>2061</fpage>             <lpage>2065</lpage>          </element-citation></ref>
<ref id="pmed.1000353-Qureshi2"><label>81</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Qureshi</surname><given-names>AI</given-names></name>
<name name-style="western"><surname>Palesch</surname><given-names>YY</given-names></name>
<name name-style="western"><surname>Martin</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Novitzke</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Cruz-Flores</surname><given-names>S</given-names></name>
<etal/></person-group>             <year>2010</year>             <article-title>Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study.</article-title>             <source>Arch Neurol</source>             <volume>67</volume>             <fpage>570</fpage>             <lpage>576</lpage>          </element-citation></ref>
</ref-list><glossary><title>Abbreviations</title><def-list><def-item>
<term>95% CI</term>
<def>
<p>95% confidence interval</p>
</def>
</def-item><def-item>
<term>ICH</term>
<def>
<p>intracerebral haemorrhage</p>
</def>
</def-item><def-item>
<term>OR</term>
<def>
<p>odds ratio</p>
</def>
</def-item><def-item>
<term>RCT</term>
<def>
<p>randomised controlled trial</p>
</def>
</def-item></def-list></glossary>
<fn-group><fn fn-type="other"><p><bold>Provenance:</bold> Commissioned; externally peer reviewed.</p></fn></fn-group>
</back>
</article>